#1 Clinical Trials Search in Europe

SUMATRIPTAN

Sumatriptan is a widely studied medication for treating migraines and cluster headaches. Clinical trials have investigated various formulations including oral tablets, nasal sprays, subcutaneous injections, and innovative delivery systems. These studies explore sumatriptan’s effectiveness in relieving migraine pain, its pharmacokinetic properties, and its safety profile across different patient populations. Understanding how sumatriptan performs in clinical trials helps healthcare providers make informed decisions about migraine treatment options. This article examines key findings from clinical research on sumatriptan, highlighting its mechanisms, effectiveness, and potential benefits for patients suffering from migraine headaches.

Table of Contents

What is Sumatriptan?

Sumatriptan is a medication that belongs to a class of drugs known as triptans. It is primarily used for treating migraine headaches. Sumatriptan is also known by the brand names Imitrex®, Imigran, ONZETRA® Xsail®, SUMAVEL® DosePro®, and Treximet (when combined with naproxen sodium)[1][2]. This medication was developed specifically to target and relieve migraine pain and associated symptoms.

Medical Uses

Sumatriptan is primarily used for:

  • Acute migraine attacks with or without aura – Sumatriptan is not designed to prevent migraines but rather to treat them once they have started[3]
  • Cluster headaches – In certain formulations, it can be effective for these intense, recurring headaches[4]
  • Post-traumatic headache – Research suggests it may be effective for headaches that develop after traumatic brain injury[5]

Sumatriptan is most effective when taken at the first sign of a migraine attack rather than waiting until the pain becomes severe. It helps to relieve pain and other migraine symptoms such as nausea, vomiting, sensitivity to light, and sensitivity to sound[6].

How Sumatriptan Works

Sumatriptan works by stimulating specific serotonin receptors in the brain, particularly the 5-HT1B receptor. When activated, these receptors cause several effects that help relieve migraine pain[7]:

  • Constriction of dilated blood vessels in the brain that are thought to contribute to migraine pain
  • Reduction of inflammation around blood vessels in the meninges (the protective layers covering the brain)
  • Inhibition of pain signal transmission through the trigeminal nerve pathway

The medication primarily acts on blood vessels and nerve endings in the brain, not on pain receptors throughout the body. This targeted approach is why sumatriptan is effective specifically for migraine headaches but not for other types of pain[8].

Different Formulations

Sumatriptan is available in several different formulations, each with different ways of delivering the medication to your body[9]:

  • Oral tablets (typically 25mg, 50mg, or 100mg) – These are swallowed and absorbed through the digestive system
  • Subcutaneous injections (usually 4mg or 6mg) – Delivered under the skin using devices like the IMITREX STATdose System® or SUMAVEL® DosePro®
  • Nasal sprays (typically 5mg, 10mg, or 20mg) – Sprayed into the nostril and absorbed through the nasal membranes
  • Nasal powder (ONZETRA® Xsail®) – A newer formulation that delivers sumatriptan as a dry powder into the nose
  • Transdermal patches (like NP101) – Deliver medication through the skin
  • Combination products (like Treximet which combines sumatriptan with naproxen sodium)

Each formulation has different advantages in terms of how quickly it works and how convenient it is to use. For example, the subcutaneous injection works fastest (within minutes) but is more invasive, while oral tablets are easy to take but may work more slowly[10].

Effectiveness

Clinical trials have shown that sumatriptan is effective for treating migraine attacks[11]. Research indicates:

  • Pain relief: Sumatriptan provides significant headache relief within 2 hours for many patients
  • Pain freedom: A notable percentage of patients become completely pain-free within 2 hours after taking sumatriptan
  • Relief of associated symptoms: Sumatriptan also helps reduce nausea, vomiting, sensitivity to light, and sensitivity to sound
  • Improved function: Patients taking sumatriptan often report improved ability to function and reduced disability

The effectiveness varies depending on the formulation used. For example, in one study comparing different formulations[3]:

  • Subcutaneous injection (6mg) provided the fastest relief
  • Oral tablets (100mg) provided longer-lasting relief
  • Nasal formulations offered an intermediate option with relatively quick onset and good tolerability

Researchers continue to develop new formulations to improve effectiveness, speed of onset, and reduce side effects[12].

Side Effects

Like all medications, sumatriptan can cause side effects, although not everyone experiences them. Common side effects include[3]:

  • Tingling or warm/hot sensation – Often felt in the face, head, or chest
  • Dizziness or lightheadedness
  • Fatigue or drowsiness
  • Feeling of tightness or pressure – Usually in the chest, throat, or jaw
  • Nausea
  • Muscle pain
  • Injection site reactions – For injectable forms, including pain, redness, or swelling
  • Nasal discomfort – For nasal forms, including irritation or unpleasant taste

More serious but rare side effects that require immediate medical attention include[13]:

  • Heart-related problems – Including chest pain, rapid heartbeat, or heart attack (especially in people with cardiovascular risk factors)
  • Allergic reactions – Such as rash, itching, swelling, severe dizziness, or trouble breathing
  • Serotonin syndrome – When combined with other medications that increase serotonin levels
  • Stroke or seizures
  • Changes in vision

Because of these potential serious side effects, sumatriptan is not recommended for people with certain medical conditions, particularly heart disease, uncontrolled high blood pressure, or a history of stroke[3].

Use in Special Populations

Sumatriptan use requires special consideration in certain populations:

Pregnancy

The Sumatriptan Pregnancy Registry has collected data on sumatriptan use during pregnancy. While limited data suggest no major increase in birth defects, sumatriptan is generally not recommended during pregnancy unless the potential benefit outweighs the risk to the fetus[14]. Women who are pregnant or planning to become pregnant should discuss this with their healthcare provider.

Elderly Patients

Sumatriptan is typically used with caution in elderly patients due to the higher likelihood of cardiovascular disease and other health conditions that might increase the risk of side effects[13].

Adolescents

Some formulations of sumatriptan are being studied for use in adolescents with migraine. For example, ONZETRA® Xsail® (sumatriptan nasal powder) has been investigated for safety and efficacy in adolescents aged 12-17 years[2].

Ongoing Research

Research on sumatriptan continues to explore new uses, formulations, and combinations[15]:

  • Novel delivery methods – Such as the Sofusa™ DoseConnect™ System for transdermal delivery and OPTINOSE nasal delivery systems
  • Combination therapies – Like Treximet (sumatriptan + naproxen sodium) for enhanced effectiveness
  • Use in other conditions – Research into post-traumatic headache and other headache disorders
  • Effects on glucose metabolism – Investigating potential effects of sumatriptan on blood glucose levels
  • Understanding mechanisms – Further research into exactly how sumatriptan works in the brain and blood vessels

Scientists are also exploring how sumatriptan interacts with other medications to improve treatment strategies and minimize side effects[16].

Aspect Details
Formulations Studied – Oral tablets (25mg, 50mg, 100mg) – Subcutaneous injections (4mg, 6mg) – Nasal sprays (20mg) – Bi-directional nasal delivery (OPTINOSE SUMATRIPTAN) – Transdermal patches (NP101) – Needle-free injection systems (Sumavel DosePro) – Combination products (TREXIMA – sumatriptan/naproxen sodium)
Primary Efficacy Measurements – Pain reduction (decrease in pain intensity by at least 1 point) – Pain relief (reduction from moderate/severe to mild/none) – Pain freedom (complete elimination of headache) – Time to pain relief – Reduction in associated symptoms (nausea, light sensitivity)
Pharmacokinetic Parameters – Maximum plasma concentration (Cmax) – Time to maximum concentration (Tmax) – Area under the curve (AUC) – Relative bioavailability compared to other formulations – Onset of action (faster with subcutaneous and nasal delivery)
Safety Assessments – Adverse events monitoring – Vital signs (blood pressure, pulse) – Electrocardiograms (ECGs) – Laboratory tests (hematology, chemistry, urinalysis) – Physical examinations – Injection/application site reactions
Special Populations Studied – Healthy volunteers (for pharmacokinetic studies) – Adults with acute migraine (with or without aura) – Adolescents with migraine – Pregnant women (safety registry) – Post-traumatic headache patients – Patients with rosacea (studying mechanism of action)
Key Findings – Subcutaneous injection provides fastest relief (10-15 minutes) – Nasal formulations offer intermediate onset (15-30 minutes) – Oral tablets have slower onset (30-60 minutes) but longer duration – Novel delivery systems can improve absorption and efficacy – Different formulations meet different patient needs (speed vs. convenience) – Generally well-tolerated across most studies

FAQ

  • What is sumatriptan and how does it work for migraine? Sumatriptan is a medication that belongs to a class of drugs called triptans. It works by stimulating serotonin receptors (specifically 5-HT1B receptors) in the brain, which causes blood vessels to narrow (constrict) and reduces inflammation around the brain's blood vessels. This action helps relieve the pain and associated symptoms of migraine headaches. Sumatriptan is available in several forms, including tablets, nasal sprays, and injections, each with different onset times and effectiveness profiles.
  • How quickly does sumatriptan work to relieve migraine pain? The speed of pain relief depends on the delivery method. Clinical trials show that subcutaneous (under the skin) injections of sumatriptan work fastest, often providing relief within 10-15 minutes. Nasal formulations like OPTINOSE SUMATRIPTAN and nasal sprays begin working within 15-30 minutes. Oral tablets typically take longer, with effects beginning around 30-60 minutes after taking the medication. Studies measuring 'pain freedom' and 'pain relief' at different time points consistently show that earlier treatment of migraine attacks leads to better outcomes.
  • What different formulations of sumatriptan have been studied in clinical trials? Clinical trials have studied multiple formulations of sumatriptan: 1) Oral tablets (typically 25mg, 50mg, or 100mg doses), 2) Subcutaneous injections (usually 4mg or 6mg), 3) Standard nasal sprays (typically 20mg), 4) Advanced nasal delivery systems like OPTINOSE SUMATRIPTAN which uses a bi-directional delivery device, 5) Transdermal systems like NP101 patches that deliver medication through the skin, 6) Needle-free injection systems like Sumavel DosePro, and 7) Combination products like TREXIMA which combines sumatriptan with naproxen sodium. Each formulation has different pharmacokinetic properties affecting how quickly and effectively it relieves migraine pain.
  • What are the most common side effects of sumatriptan seen in clinical trials? Common side effects observed in clinical trials include: injection site reactions (with subcutaneous forms) such as pain, redness, and swelling; sensory symptoms like tingling, warming sensations, or discomfort in the nasal passages with nasal formulations; and systemic effects including dizziness, fatigue, throat discomfort, and nausea. Some patients experience chest tightness or pressure, which should be monitored. Most side effects are mild to moderate and temporary. The safety assessments in clinical trials typically include monitoring vital signs, electrocardiograms (ECGs), laboratory tests, and physical examinations to ensure the medication's safety profile is well understood.
  • How effective is sumatriptan compared to placebo for treating migraines? Clinical trials consistently show that sumatriptan is significantly more effective than placebo for treating migraines. For example, in studies of OPTINOSE SUMATRIPTAN, more patients achieved pain reduction and pain freedom at various time points (30 minutes, 60 minutes, 2 hours) compared to placebo. One study showed that sumatriptan powder delivered intranasally provided superior pain reduction at 30 minutes compared to oral tablets. Efficacy measures typically include pain reduction (decrease in pain intensity by at least 1 point on a scale), pain relief (reduction from moderate/severe to mild/none), and pain freedom (complete elimination of headache). Sumatriptan also helps relieve associated symptoms like nausea and sensitivity to light and sound.

Ongoing Clinical Trials on SUMATRIPTAN

  • Study on Sumatriptan and Rimegepant for Treating Nitroglycerin-Induced Headaches in Patients with Episodic Migraine

    Recruiting

    1 1 1 1
    Investigated drugs:
    Spain

  • Study of the effects of pitolisant on migraine without aura in women

    Not yet recruiting

    1 1
    Investigated drugs:
    Denmark

Glossary

  • AUC (Area Under the Curve): A measurement used in pharmacokinetic studies that represents the total exposure to a drug over time. It's calculated as the area under the plasma concentration-time curve and helps determine how much of a drug reaches the bloodstream.
  • Bioavailability: The proportion of a drug that enters the circulation when introduced into the body and is available to have an active effect. Different formulations of sumatriptan (oral, nasal, subcutaneous) have different bioavailability profiles.
  • Cmax: The maximum concentration of a drug in the blood, plasma, or serum after administration. This measurement is important for understanding how much of the drug is available at peak levels in the body.
  • Crossover Study: A type of clinical trial where participants receive a sequence of different treatments over time. For example, a patient might receive sumatriptan in one period and placebo in another, allowing comparison of effects in the same individual.
  • Double-blind: A study design where neither the participants nor the researchers know who is receiving which treatment. This helps prevent bias in assessing the treatment's effects.
  • IMITREX: The brand name for sumatriptan, available in various formulations including tablets, nasal spray, and injection. It was one of the first triptans approved for migraine treatment.
  • Migraine Without Aura: A type of migraine headache not preceded by visual disturbances or other neurological symptoms (known as aura). It typically presents as a throbbing pain on one side of the head with nausea, vomiting, and sensitivity to light and sound.
  • OPTINOSE SUMATRIPTAN: A delivery system for sumatriptan that uses a bi-directional nasal delivery device designed to deliver medication higher into the nasal cavity for potentially faster absorption and relief of migraine symptoms.
  • Pharmacodynamics: The study of how a drug affects the body, including the biochemical and physiological effects and their mechanisms of action. For sumatriptan, this involves how it activates specific serotonin receptors.
  • Pharmacokinetics (PK): The study of how the body processes a drug, including absorption, distribution, metabolism, and excretion. PK studies for sumatriptan examine how quickly it enters the bloodstream, how long it stays active, and how it's eliminated.
  • Placebo: An inactive substance that looks like the drug being tested but has no therapeutic effect. In clinical trials, placebos are used as a control to determine if the active drug provides a real benefit.
  • Post-traumatic Headache: A secondary headache disorder that develops after traumatic brain injury. Some clinical trials have investigated sumatriptan as a potential treatment for this condition.
  • SPID-30: Sum of Pain Intensity Differences at 30 minutes, a measurement used in clinical trials to assess how effectively a treatment reduces pain over the first 30 minutes after administration.
  • Subcutaneous: Under the skin. Subcutaneous injections of sumatriptan deliver medication into the fatty tissue just beneath the skin, allowing for rapid absorption into the bloodstream.
  • Tmax: The time it takes for a drug to reach its maximum concentration in the blood after administration. Different formulations of sumatriptan have different Tmax values, affecting how quickly they relieve migraine pain.
  • TREXIMA: A combination medication containing sumatriptan and naproxen sodium, designed to treat migraine headaches through multiple mechanisms of action.

References

  1. https://clinicaltrials.gov/study/NCT00875784
  2. https://clinicaltrials.gov/study/NCT03338920
  3. https://clinicaltrials.gov/study/NCT01667679
  4. https://clinicaltrials.gov/study/NCT00356603
  5. https://clinicaltrials.gov/study/NCT01854385
  6. https://clinicaltrials.gov/study/NCT01016834
  7. https://clinicaltrials.gov/study/NCT02932488
  8. https://clinicaltrials.gov/study/NCT03878784
  9. https://clinicaltrials.gov/study/NCT01507610
  10. https://clinicaltrials.gov/study/NCT00546650
  11. https://clinicaltrials.gov/study/NCT01462812
  12. https://clinicaltrials.gov/study/NCT03229798
  13. https://clinicaltrials.gov/study/NCT01376141
  14. https://clinicaltrials.gov/study/NCT01059604
  15. https://clinicaltrials.gov/study/NCT04690270
  16. https://clinicaltrials.gov/study/NCT04355845